Rudenko, I. N., Chia, R., & Cookson, M. R. (2012). Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? BioMed Central.
Chicago Style citaatRudenko, Iakov N., Ruth Chia, en Mark R. Cookson. Is Inhibition of Kinase Activity the Only Therapeutic Strategy for LRRK2-associated Parkinson's Disease? BioMed Central, 2012.
MLA citatieRudenko, Iakov N., Ruth Chia, en Mark R. Cookson. Is Inhibition of Kinase Activity the Only Therapeutic Strategy for LRRK2-associated Parkinson's Disease? BioMed Central, 2012.
Let op: Deze citaties zijn niet altijd 100% accuraat.